INmune Bio, Inc. (INMB)
1.385
-0.02
(-1.77%)
USD |
NASDAQ |
May 21, 12:57
INmune Bio EPS Diluted (Quarterly) : -0.2034 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PDS Biotechnology Corp. | -0.1324 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.407M |
| Total Expenses (Quarterly) | 5.407M |
| Enterprise Value | 17.64M |
| Earnings Yield | -122.4% |
| Normalized Earnings Yield | -87.67 |